Clinical Trial

Study to Investigate the Efficacy and Safety of SC0023, in Adults With Refractory or Unexplained Chronic Cough

Study acronym: REACH
Completed
View on ClinicalTrials.gov →
Summary
This is a randomized, double-blind, placebo controlled cross-over study to investigate the efficacy and safety of SC0023 (an oral spray of magnesium based alkaline hypertonic divalent salt) in adults with refractory or unexplained chronic cough over 14 days. Approximately 20 participants being enrolled and randomized into the study.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-25.
Status change: Recruiting → Completed 2026-01-19
Trial Details
NCT Number NCT07003347
Lead Sponsor Kholood Altassan
Conditions Chronic Cough
Enrollment 7 participants
Start Date 2024-12-19
Primary Completion 2025-07-30 (estimated)
Study Completion 2025-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-21